Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ALZHEIMER DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ALZHEIMER DISEASE is a gene implicated in neurodegeneration research. Key relationships include: interacts with, activates, associated with. Associated with ALS, Aging, Als. Connected to 753 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ALZHEIMER DISEASE |
| Primary Expression | Ca1, Cortex, Hippocampus |
| Pathways | Autophagy, Oxidative Stress, Stem Cell, Complement, Immune Response |
| Associated Diseases | Aging, Als, Alzheimer, Amyotrophic Lateral Sclerosis, Atherosclerosis |
| Known Drugs/Compounds | ANTI-AΒ ANTIBODIES, ds-cRNA |
| Interactions | ABCA1, ABCD3, ABI3, ACE, ACHE, ADAM10 |
| KG Connections | 1343 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
graph TD
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"therapeutic target"| Alzheimer["Alzheimer"]
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"therapeutic target"| Ms["Ms"]
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"therapeutic target"| Cancer["Cancer"]
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"therapeutic target"| Diabetes["Diabetes"]
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"activates"| Alzheimer_1["Alzheimer"]
ALZHEIMER_DISEASE["ALZHEIMER DISEASE"] -->|"activates"| Anxiety["Anxiety"]
TREM2["TREM2"] -->|"associated"| ALZHEIMER_DISEASE["ALZHEIMER DISEASE"]
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"therapeutic target"| ALZHEIMER_DISEASE["ALZHEIMER DISEASE"]
AKT1["AKT1"] -->|"therapeutic target"| ALZHEIMER_DISEASE["ALZHEIMER DISEASE"]
EGFR["EGFR"] -->|"therapeutic target"| ALZHEIMER_DISEASE["ALZHEIMER DISEASE"]
style ALZHEIMER_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer | activates | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Dementia | biomarker_for | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Neurodegeneration | biomarker_for | disease | 0.95 |
| Neurodegeneration | therapeutic_target | disease | 0.95 |
| Molecular Heterogeneity | associated_with | process | 0.95 |
| Alzheimer | biomarker_for | disease | 0.95 |
| Parkinson | associated_with | disease | 0.95 |
| Inflammation | associated_with | disease | 0.95 |
| Amyloid Beta 42/40 | markers | protein | 0.90 |
| TREM2 | associated_with | gene | 0.90 |
| APOE4 | markers | protein | 0.90 |
| ANTI-AΒ ANTIBODIES | targets | drug | 0.90 |
| P-Tau | markers | protein | 0.90 |
| PSEN1 | associated_with | gene | 0.90 |
| Premature Senescence | causes | phenotype | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| DEMENTIA | biomarker_for | gene | 0.90 |
| ALZHEIMER | associated_with | gene | 0.90 |
| APOE | activates | gene | 0.90 |
| ALZHEIMER | activates | gene | 0.90 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Alzheimer | causes | disease | 0.85 |
| Neurodegeneration | inhibits | disease | 0.85 |
| Cancer | associated_with | disease | 0.85 |
| Dementia | associated_with | disease | 0.85 |
| Aging | activates | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Neuroinflammation | associated_with | disease | 0.85 |
| Obesity | associated_with | disease | 0.85 |
| Blood-Brain Barrier Dysfunction | associated_with | phenotype | 0.85 |
| Aging | biomarker_for | disease | 0.85 |
| Als | biomarker_for | disease | 0.85 |
| CD33 | associated_with | gene | 0.80 |
| SORL1 | associated_with | gene | 0.80 |
| CD2AP | associated_with | gene | 0.80 |
| SIGLEC11 | associated_with | gene | 0.80 |
| PTK2B | associated_with | gene | 0.80 |
| BLNK | associated_with | gene | 0.80 |
| PLCG2 | associated_with | gene | 0.80 |
| SPI1 | associated_with | gene | 0.80 |
| TMEM106B | associated_with | gene | 0.80 |
| LRP1 | associated_with | gene | 0.80 |
| ADAM17 | associated_with | gene | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| AGING | associated_with | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Blood Test | biomarker_for | biomarker | 0.98 |
| Amyloid Probability Score 2 | biomarker_for | biomarker | 0.98 |
| APOE | associated_with | gene | 0.95 |
| ISG15 | implicated_in | gene | 0.95 |
| MAPT | biomarker_for | protein | 0.95 |
| Amyloid-Beta 40 | biomarker_for | protein | 0.95 |
| P-Tau217 | biomarker_for | biomarker | 0.95 |
| TAU | associated_with | protein | 0.95 |
| Amyloid-Beta 42 | biomarker_for | protein | 0.95 |
| Macrophages | contributes_to | cell_type | 0.95 |
| Immune Activation | contributes_to | process | 0.95 |
| Phosphorylated Tau 217 | biomarker_for | biomarker | 0.95 |
| MAPT | causes | gene | 0.95 |
| Mitochondrial Dysfunction | contributes_to | process | 0.95 |
| Amyloid-beta | biomarker_for | biomarker | 0.95 |
| Γ-SECRETASE | involved_in | enzyme | 0.95 |
| APOE ε4 | risk_factor_for | protein | 0.95 |
| AMYLOID-Β | associated_with | protein | 0.95 |
| Aβ42:Aβ40 Ratio | biomarker_for | biomarker | 0.95 |
| Anti-Aβ Antibodies | treats | drug | 0.95 |
| APOE | protects_against | gene | 0.95 |
| AMYLOID BETA | involved_in | protein | 0.95 |
| Microglial Phagocytosis | causes | process | 0.95 |
| APOE ε4 Allele | risk_factor_for | biomarker | 0.95 |
| Microglia | contributes_to | cell_type | 0.95 |
| Phosphorylated Tau at Threonine 181 | biomarker_for | biomarker | 0.95 |
| Amyloid-Beta Plaque Deposition | biomarker_for | biomarker | 0.95 |
| Oxidative Stress | contributes_to | process | 0.95 |
| AMYLOID-BETA | associated_with | protein | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| Donanemab | treats | drug | 0.95 |
| Cellular Senescence | contributes_to | process | 0.95 |
| Neurofibrillary Tangles | associated_with | phenotype | 0.95 |
| Amyloid Reduction | therapeutic_target | mechanism | 0.95 |
| Neuritic Plaques | associated_with | phenotype | 0.95 |
| BETA-AMYLOID | biomarker_for | protein | 0.95 |
| TAU | biomarker_for | protein | 0.95 |
| Amyloid-β | biomarker_for | biomarker | 0.95 |
| Amyloid-Beta Accumulation | contributes_to | phenotype | 0.95 |
| Amyloid-β Accumulation | contributes_to | phenotype | 0.95 |
| APOE*ε4 | risk_factor_for | biomarker | 0.95 |
| Ageing | risk_factor_for | process | 0.95 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.583
neurodegeneration | 2026-04-23 | 8 hypotheses Top: 0.680
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning ALZHEIMER DISEASE in their description or question text
No additional research found